Insider Trading25 Sept 2026, 09:46 am
Ajanta Pharma Closes Trading Window for Q2 FY27 Results
AI Summary
Ajanta Pharma Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal code of conduct. The trading window will be shut from Thursday, October 1, 2026, until 48 hours after the declaration of the financial results for the second quarter and half-year ended September 30, 2026. This measure is standard practice to prevent insider trading during periods when material non-public information might be available.
Key Highlights
- Trading window closed from October 1, 2026.
- Closure is for Q2 and H1 FY27 financial results announcement.
- Effective until 48 hours post-results declaration.
- Aims to prevent insider trading activities.
- Standard corporate governance procedure.
Price Impact
More from AJANTPHARM